- Net sales amounted to TSEK 305 (TSEK 50).
-
Earnings before interest and taxes (EBIT) amounted to TSEK -5 363 (TSEK -6 263).
Earning per share before dilution atSEK -0,07 (SEK -0,09 ). - Cash flow from operating activities amounted to TSEK -6 730 (TSEK -5 834).
- Cash and cash equivalents at the end of the period TSEK 4 739 (TSEK 13 163).
- Equity ratio was 77 % (85 %).
SUMMARY OF EVENTS DURING FIRST QUARTER
- RLS' notified bodies have carried out quality audits (ISO 13485 and MDD) without remarks. RLS is in the MDR review process which will be completed according to plan.
-
The CEO
Karin Fischer has handed in her resignation and a process to find her successor has started. -
RLS has started to transfer contracts with regions to
ConvaTec . -
ChloraSolv is delivered to
ConvaTec 's central warehouse inthe Netherlands on a regular basis. -
ChloraSolv is reimbursed in
the Netherlands . -
As RLS has no business in
Russia ,Ukraine orBelarus , the situation there will have no direct impact on RLS.
TRADING PLACE AND CERTIFIED ADVISER
The Interim Report Q1, 2022, is enclosed and is also available here.
PUBLICATION
This information was submitted for publication through the agency of the below contact person, at 09.00 CET on
CONTACT INFORMATION
E-mail: karin.fischer@rlsglobal.se
Telephone: +46 702-48 46 51
Eva Jagenheim, CFO
E-mail: eva.jagenheim@rlsglobal.se
Telephone: +46 31 780 68 20
About
https://news.cision.com/rls-global-ab/r/rls-global-ab--publ--interim-report--q1--2022,c3564363
https://mb.cision.com/Main/12052/3564363/1577627.pdf
(c) 2022 Cision. All rights reserved., source